XAGEW

Investor Moves

Name	Value	Action	Change	Price	Last Price
Ken GriffinCitadel Advisors $-5.6K ExitQ2 2025 $5.6k -- $0.01
Ken GriffinCitadel Advisors $-48.5K TrimQ1 2025 $48k -- $0.01

Insider Trades

Name	Value	Action	Price	Last Price
Ajjarapu J. RamDirector, 10 Percent Owner, Officer: Chief Executive Officer $200k689.7k shares BuyMar 16, 2026 $0.29 $0.01
Upton Richard ADirector $2.3k5k shares BuySep 13, 2024 $0.4672 $0.01
Cassaday Bryan J.Chief Financial Officer $219475 shares BuySep 10, 2024 $0.46 $0.01
Sturgeon Patrick ADirector $6431.3k shares BuySep 6, 2024 $0.51 $0.01
Gregory KathrynDirector $6431.3k shares BuySep 6, 2024 $0.51 $0.01
Spenlehauer GillesDirector $5151k shares BuySep 6, 2024 $0.51 $0.01

Trade XAGEW

About Longevity Health Holdings Inc.

Longevity Health Holdings Inc. is dedicated to advancing plasma-derived bioactive materials (PBMs) designed to stimulate tissue regeneration and recovery following injuries, illnesses, or age-related decline. Their primary product in development, CT-101, functions both as an accelerant for bone healing—with intended uses including the repair of tibia fractures, facilitating foot and ankle fusions, aiding spinal fusions, substituting for dental bone grafts, and filling bone voids—and as a tissue healing accelerator for conditions such as androgenetic alopecia and persistent wounds. This company was established in 2008 and is based in Pittsburgh, Pennsylvania.

CEO: Janakiram Ajjarapu
IPO Date: Mar 20, 2025

Market Data

Open: $0.01
High: $0.01
Low: $0.01
Volume: 16.1K
Avg Volume: 25.8K
52W High: $0.01
52W Low: $0.01

Valuation

Market Cap: $9K
Enterprise Value: $506.1K
Dividend Yield: 0.00%

Financials

Free Cash Flow: -$3.3M
Revenue: $1.9M
Net Income: -$6.9M
Cash: $706.7K
Debt: $499.9K

Events

IPOMar 20

NASDAQ